Abstract
3-Amino-2-hydroxy-4-phenylbutyric acids (AHPA or alternatively abbreviated AHPBA) serve as chiral building blocks for various bioactive compounds including aminopeptidase N (APN) inhibitors, HIV-l protease inhibitors, and renin inhibitors. The synthesis of α-hydroxy-β-amino acids has therefore attracted considerable interest in recent years and various synthetic approaches have been developed to complete their synthesis. These strategies include utilization of enantiopure starting materials like sugars and amino acids and introduction of bulky groups to achieve the desired stereoselectivity and asymmetric catalysis using enzymes or inorganic catalysts to achieve the desired stereochemistry. This review will discuss these synthetic strategies.
Keywords: AHPA, asymmetric synthesis, catalysts, chiral synthons, enantioselective synthesis, stereoselective synthesis, AHPBA, aminopeptidase N (APN) inhibitors, HIV-l protease inhibitors, synthetic strategies
Mini-Reviews in Organic Chemistry
Title: Overview of the Synthesis of Optically Active 3-Amino-2-Hydroxy-4-Phenylbutyric Acids, Key Intermediates for Numerous Bioactive Compounds
Volume: 8 Issue: 2
Author(s): Meirong Jia, Tao Wei, Kanghui Yang and WenFang Xu
Affiliation:
Keywords: AHPA, asymmetric synthesis, catalysts, chiral synthons, enantioselective synthesis, stereoselective synthesis, AHPBA, aminopeptidase N (APN) inhibitors, HIV-l protease inhibitors, synthetic strategies
Abstract: 3-Amino-2-hydroxy-4-phenylbutyric acids (AHPA or alternatively abbreviated AHPBA) serve as chiral building blocks for various bioactive compounds including aminopeptidase N (APN) inhibitors, HIV-l protease inhibitors, and renin inhibitors. The synthesis of α-hydroxy-β-amino acids has therefore attracted considerable interest in recent years and various synthetic approaches have been developed to complete their synthesis. These strategies include utilization of enantiopure starting materials like sugars and amino acids and introduction of bulky groups to achieve the desired stereoselectivity and asymmetric catalysis using enzymes or inorganic catalysts to achieve the desired stereochemistry. This review will discuss these synthetic strategies.
Export Options
About this article
Cite this article as:
Jia Meirong, Wei Tao, Yang Kanghui and Xu WenFang, Overview of the Synthesis of Optically Active 3-Amino-2-Hydroxy-4-Phenylbutyric Acids, Key Intermediates for Numerous Bioactive Compounds, Mini-Reviews in Organic Chemistry 2011; 8 (2) . https://dx.doi.org/10.2174/157019311795177754
DOI https://dx.doi.org/10.2174/157019311795177754 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mesenchymal Stromal Cells Uptake and Release Paclitaxel without Reducing its Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
Current Cancer Drug Targets Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design Myokines in Myogenesis and Health
Recent Patents on Biotechnology Small Interfering RNA for Effective Cancer Therapies
Mini-Reviews in Medicinal Chemistry Chemomodulating Effects of Flavonoids in Human Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Anticancer Activity of New Compounds Using Benzimidazole as a Scaffold
Anti-Cancer Agents in Medicinal Chemistry The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature
Cardiovascular & Hematological Agents in Medicinal Chemistry Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design New Antitumour Natural Products from Marine Red Algae: Covering the Period from 2003 to 2012
Mini-Reviews in Medicinal Chemistry Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Novel and Emerging Drugs for Acute Lymphoblastic Leukemia
Current Cancer Drug Targets Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
Current Cancer Drug Targets Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
Current Medicinal Chemistry The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors
Current Radiopharmaceuticals Emerging Treatments in Acute Lymphoblastic Leukemia
Current Cancer Drug Targets Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents
Current Pharmaceutical Design